Work

CNS metastases as a site of progression on SWOG intergroup study S0008: A phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 (BCT) versus high-dose interferon (HDI) in patients with high-risk melanoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8527

Authors: Wolfram E. Samlowski, James Moon, Merle Witter, Michael B. Atkins, John M. Kirkwood, Megan Othus, Antoni Ribas, Vernon K. Sondak, Lawrence E. Flaherty

Institutions: Comprehensive Cancer Centers of Nevada, SWOG Cancer Research Network, Beth Israel Deaconess Medical Center, UPMC Hillman Cancer Center, University of California, Los Angeles, Moffitt Cancer Center, Wayne State University

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597602008

Cites:

Cited by: 2

Related to: 10